ANESTHESIA ENDOTRACHEAL TUBE MARKET ANALYSIS

Market Challenges And Opportunities

• Lack of proper health care facilities especially in the underdeveloped countries as well as in remote areas
• Product recalls
• Presence of few anesthetists and certified nurses per capita of population 

Global Anesthesia Endotracheal Tube Market: Restraint

The major factors that hinder growth of the global anesthesia endotracheal tube market include lack of proper health care facilities especially in the underdeveloped countries as well as in remote areas. Lack of proper health care facilities especially in the underdeveloped countries as well as in remote areas, product recalls and presence of few anesthetists and certified nurses per capita of population are likely to inhibit growth of the anesthesia endotracheal tube in the anesthesia endotracheal tube market. For instance, in November 2017, according to the National Center for Biotechnology Information, endotracheal intubation is the placement of a tube into the trachea, either orally or nasally for airway management. Airway management is one of the most important skills of the physician. Failure to provide required airflow can cause death or sequelae of the patient, especially in emergency conditions. Intubation without medication to trauma patients with high Glasgow Coma Scale is not safe, resulting in intracranial pressure increase, vomiting, esophageal intubation, and aspiration risk. Special procedures are required in pediatric patients and newborns, and their indications for endotracheal intubation can show variability.

Global Anesthesia Endotracheal Tube Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global anesthesia endotracheal tube market, owing to increase in demand for patients with pulmonary disorders. For instance, in October 2021, the American Society of Anesthesiologists (ASA) and the Anesthesia Patient Safety Foundation (APSF) showed that high rates of postoperative pulmonary complications and mortality were reported in an observational international study of 1128 patients with perioperative COVID-19 who underwent a variety of surgical procedures. Pulmonary complications occurred in 51 percent of patients, among those patients 30 day mortality was 38 percent. Overall mortality was higher after emergency surgery compared with elective surgery (26 versus 19 percent), and was higher in men, in patients >70 years of age.  Of the 280 patients who had elective surgery, 22 were diagnosed with COVID-19 preoperatively and two of them died. The Anesthesia Patient Safety Foundation (APSF) and the American Society of Anesthesiologists (ASA) have issued a 2022 joint statement on elective surgery after COVID-19 infection, with general guidelines on timing of elective surgery based on the severity of symptoms at the time of infection, ongoing symptoms, comorbidities, and complexity of surgery. Several guidelines developed during the COVID-19 pandemic recommended routinely performing rapid sequence induction and intubation (RSII) for patients with COVID-19, primarily to avoid the aerosol generation that may be associated with mask ventilation.